CYMERE Trademark

Trademark Overview


On Friday, July 19, 2019, a trademark application was filed for CYMERE with the United States Patent and Trademark Office. The USPTO has given the CYMERE trademark a serial number of 79266160. The federal status of this trademark filing is IR CANCELLED - NO TRANSFORMATION FILED as of Friday, October 1, 2021. This trademark is owned by Exopharm Limited. The CYMERE trademark is filed in the Pharmaceutical Products category with the following description:

Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease
cymere

General Information


Serial Number79266160
Word MarkCYMERE
Filing DateFriday, July 19, 2019
Status401 - IR CANCELLED - NO TRANSFORMATION FILED
Status DateFriday, October 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, June 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExopharm Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Sunday, July 18, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, July 17, 2021DEATH OF INTERNATIONAL REGISTRATION
Monday, February 22, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, February 8, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, December 18, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 26, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 25, 2020ASSIGNED TO LIE
Tuesday, May 26, 2020ASSIGNED TO EXAMINER
Friday, December 20, 2019REFUSAL PROCESSED BY IB
Tuesday, November 26, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 26, 2019REFUSAL PROCESSED BY MPU
Tuesday, November 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 4, 2019SUSPENSION LETTER WRITTEN
Wednesday, October 30, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, October 10, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 9, 2019SUSPENSION LETTER WRITTEN
Friday, October 4, 2019ASSIGNED TO EXAMINER
Friday, September 13, 2019APPLICATION FILING RECEIPT MAILED
Monday, September 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 29, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB